venlafaxine hydrochloride has been researched along with Disease Models, Animal in 78 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (20.51) | 29.6817 |
| 2010's | 51 (65.38) | 24.3611 |
| 2020's | 11 (14.10) | 2.80 |
| Authors | Studies |
|---|---|
| Gruca, P; Lason, M; Litwa, E; Papp, M; Solecki, W; Willner, P | 2 |
| Huang, F; Shen, W; Shi, H; Tao, Y; Wu, H; Wu, X; Zheng, F; Zhou, H | 1 |
| Audano, M; Brivio, P; Calabrese, F; Fumagalli, F; Gallo, MT; Gruca, P; Lason, M; Litwa, E; Miceli, E; Mitro, N; Papp, M | 1 |
| Chen, L; Gan, L; Huang, C; Liao, Z; Liu, C; Su, T; Yuan, M; Zhang, L | 1 |
| Bijak, M; Czarny, P; Gruca, P; Jóźwiak, P; Papp, M; Śliwiński, T; Synowiec, E; Szemraj, J; Wigner, P | 1 |
| Brink, CB; Harvey, BH; Steyn, SF | 1 |
| Bowman, MA; Daws, LC; Horton, RE; Koek, W; Mitchell, NC; Owens, WA | 1 |
| Chen, TT; Gao, TT; Guan, W; Jiang, B; Liu, L; Wang, JL; Wang, Y; Wang, YJ; Zhang, Y; Zhao, J | 1 |
| Belovičová, K; Bögi, E; Dubovický, M; Noguera, MV; Šimončičová, E | 1 |
| Budziszewska, B; Detka, J; Głombik, K | 1 |
| Andrei, C; Chirita, C; Ciotu, CI; Fischer, MJM; Mihai, DP; Negres, S; Nitulescu, GM; Olaru, OT; Seremet, OC; Ungurianu, A; Zanfirescu, A; Zbarcea, CE | 1 |
| Belovicova, K; Bogi, E; Dubovicky, M; Koprdova, R; Mach, M; Ujhazy, E | 1 |
| Fijałkowski, Ł; Malikowska, N; Nowaczyk, A; Popik, P; Sałat, K | 1 |
| Alboghobeish, S; Amirgholami, N; Ghorbanzadeh, B; Houshmand, G; Mansouri, MT; Naghizadeh, B | 1 |
| Kus, K; Nowakowska, E; Ratajczak, P; Skurzyńska, M | 1 |
| Alboghobeish, S; Amirgholami, N; Cauli, O; Ghorbanzadeh, B; Houshmand, G; Mansouri, MT; Naghizadeh, B | 1 |
| Gruca, P; Lason, M; Litwa, E; Niemczyk, M; Papp, M; Tota-Glowczyk, K; Willner, P | 2 |
| Fawzy, HM; Gad, AM; Kamel, KM; Mansour, SM; Safar, MM | 1 |
| Chen, S; Feng, ZP; Guo, Z; Huang, J; Mu, N; Wang, H; Wang, R; Wen, Q; Zheng, W; Zhou, X | 1 |
| Alén, F; de Fonseca, FR; de Heras, RG; Gorriti, MÁ; Orio, L; Pozo, MÁ; Ramírez-López, MT | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Ago, Y; Fujita, K; Hiramatsu, N; Kawanai, T; Matsuda, T; Takuma, K; Umehara, M | 1 |
| Bijlsma, EY; Chan, JS; Millan, MJ; Olivier, B; Oosting, RS; Veening, JG; Waldinger, MD | 1 |
| Ali, J; Baboota, S; Haque, S; Md, S; Sahni, JK | 1 |
| Jagla, G; Makuch, W; Mika, J; Obara, I; Przewlocka, B; Wordliczek, J | 1 |
| Coudoré, F; Gardier, AM; Guiard, BP; Hache, G; Munro, G; Nguyen, TH; Peters, D; Quesseveur, G | 1 |
| Huang, X; Ji, JL; Li, C; Mao, YS; Wang, H | 1 |
| Dikshit, M; Shukla, S; Singh, KP; Singh, M | 1 |
| Butler, P; Munafò, MR; Nutt, DJ; Robinson, ES; Stuart, SA | 1 |
| Chen, C; Chen, F; Lu, YN; Zhai, XJ; Zhu, CR | 1 |
| Carlini, VP; de Cuneo, MF; Perez, MF; Poretti, MB; Rask-Andersen, M; Sawant, RS; Schiöth, HB | 1 |
| Guo, L; Jiang, HF; Wang, Y; Zhang, A; Zhen, XC; Zheng, LT | 1 |
| Sharma, B; Singh, P | 1 |
| Khanam, R; Thomas, J; Vohora, D | 1 |
| Antoniów, M; Grześkowiak, E; Kus, K; Nowakowska, E; Ratajczak, P; Szkutnik-Fiedler, D | 1 |
| Bronfman, FC; Contreras, V; Lazo, OM; Owen, GI; Pissani, C; Stack, K; Vargas, M; Zepeda, R | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Arini, A; Basu, N; Bellanger, C; Bidel, F; Budzinski, H; Callewaert, W; Di Poi, C; Dickel, L; Jozet-Alves, C; Pardon, P | 1 |
| Huang, S; Liu, C; Liu, X; Ye, Y | 1 |
| Brand, SJ; Harvey, BH | 1 |
| Dong, J; Gu, JY; Li, Y; Ning, QF; Shan, XW; Wang, CH; Yang, J; Zhang, XL; Zhang, YL | 1 |
| Deshmukh, R; Gill, JS; Jamwal, S; Kumar, P | 1 |
| Kálmán, J | 1 |
| Dhir, A; Kulkarni, SK | 2 |
| Berlanga, C; Estrada-Camarena, E; Fernández-Guasti, A; Rivera, NM | 1 |
| Garg, R; Gaur, V; Kumar, A; Kumar, P | 1 |
| Obara, I; Przewlocka, B; Wordliczek, J; Wrzosek, A | 1 |
| Hay-Schmidt, A; Larsen, MH; Mikkelsen, JD; Sandi, C | 1 |
| Gaur, V; Kumar, A | 1 |
| Krass, M; Vasar, E; Volke, V; Wegener, G | 1 |
| Dhir, A; Kessar, SV; Kulkarni, SK; Malik, S; Singh, KN | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Cure, MC; Demirdas, A; Eren, I; Kirbas, A; Sutcu, R; Yilmaz, M; Yilmaz, N | 1 |
| Bacq, A; Balasse, L; Biala, G; Chevarin, C; Gardier, AM; Gautron, S; Giros, B; Guiard, B; Hamon, M; Louis, F; Martres, MP; Schinkel, A; Vialou, V | 1 |
| Dai, MH; Han, Y; Li, DQ | 1 |
| Liu, MM; Shi, HS; Si, JJ; Sun, LL; Suo, L; Wu, P; Yang, CH; Yang, JL; Zhang, Y; Zhu, WL | 1 |
| Liu, J; Qiao, W; Ren, L; Sun, Y; Wang, S; Yang, Y | 1 |
| Cui, J; Du, GH; Gao, XX; Li, ZF; Li, ZY; Liu, XJ; Qin, XM; Sun, HF; Zhang, LZ; Zhou, YZ | 1 |
| Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K | 1 |
| Santamaria-Cano, J | 1 |
| Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E | 1 |
| Liu, XH; Qin, J; Wang, Y; Wen, ZY; Yang, JL; Yu, JJ; Zhang, Y | 1 |
| Aisa, B; Guereñu, G; Martisova, E; Ramírez, MJ | 1 |
| Feng, W; Fenli, S; Huande, L; Ronghua, Z | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Wikell, C | 1 |
| Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Jourdan, D; Marchand, F; Pelissier, T | 1 |
| Dogru, A; Onal, A; Soykan, N; Uyar, M | 1 |
| Alloui, A; Alvarez, P; Ardid, D; Authier, N; Eschalier, A; Hernández, A; Marchand, F; Pelissier, T | 1 |
| Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Barnes, MJ; Daiss, JO; Mills, JS; Montana, JG; Showell, GA; Tacke, R; Warneck, JB | 1 |
| Aricioğlu, F; Buldanlioğlu, U; Ozyalçin, NS; Salanturoğlu, G | 1 |
| Chen, Z; Dyck, L; Haimanot, S; He, J; Li, X; Li, XM; Xu, H | 1 |
| Altunbaşak, A; Celik, O; Demirdaş, A; Eren, I; Naziroğlu, M; Ozmen, I; Uğuz, AC; Uz, E | 1 |
| Ahlner, J; Apelqvist, G; Baumann, P; Bengtsson, F; Eap, CB; Josefsson, M; Wikell, C | 1 |
3 review(s) available for venlafaxine hydrochloride and Disease Models, Animal
| Article | Year |
|---|---|
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?
Topics: Animals; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Buspirone; Cyclohexanols; Disease Models, Animal; Dopamine; Female; Humans; Indoles; Male; Norepinephrine; Paroxetine; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior, Animal; Sexual Dysfunction, Physiological; Synaptic Transmission; Venlafaxine Hydrochloride | 2014 |
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4; Benzodiazepines; Citalopram; Cyclohexanols; Disease Models, Animal; Gene Expression Regulation; Humans; Hungary; Mianserin; Mirtazapine; Oxidative Stress; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
75 other study(ies) available for venlafaxine hydrochloride and Disease Models, Animal
| Article | Year |
|---|---|
Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Optogenetics; Prefrontal Cortex; Rats; Rats, Inbred WKY; Stress, Psychological; Venlafaxine Hydrochloride | 2021 |
The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice.
Topics: Animals; Antidepressive Agents; Bacteria; Depression; Disease Models, Animal; Gastrointestinal Microbiome; Hippocampus; Mice; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2023 |
Venlafaxine's effect on resilience to stress is associated with a shift in the balance between glucose and fatty acid utilization.
Topics: Anhedonia; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Glucose; Hippocampus; Humans; Rats; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2023 |
Piperlongumine produces antidepressant-like effects in rats exposed to chronic unpredictable stress.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Cytokines; Depression; Dioxolanes; Disease Models, Animal; Hippocampus; Male; Motor Activity; Neuroprotective Agents; Rats; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Effects of venlafaxine on the expression level and methylation status of genes involved in oxidative stress in rats exposed to a chronic mild stress.
Topics: Animals; Brain; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation; Male; Organ Specificity; Oxidative Stress; Rats; Stress, Psychological; Sucrose; Transcriptome; Venlafaxine Hydrochloride | 2020 |
Pre-pubertal, low-intensity exercise does not require concomitant venlafaxine to induce robust, late-life antidepressant effects in Flinders sensitive line rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder, Major; Disease Models, Animal; Norepinephrine; Rats; Serotonin; Venlafaxine Hydrochloride | 2020 |
Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Dentate Gyrus; Depression; Desipramine; Disease Models, Animal; Locomotion; Male; Mice, Inbred C57BL; Norepinephrine; Organic Cation Transport Proteins; Quinolines; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2020 |
Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hippocampus; Mice; Mice, Inbred C57BL; Signal Transduction; Stress, Psychological; Venlafaxine Hydrochloride | 2020 |
Long-term effects of pre-gestational stress and perinatal venlafaxine treatment on neurobehavioral development of female offspring.
Topics: Animals; Anxiety; Behavior, Animal; Disease Models, Animal; Female; Hippocampus; Lactation; Maternal Behavior; Maze Learning; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Serotonin and Noradrenaline Reuptake Inhibitors; Sex Factors; Stress, Psychological; Venlafaxine Hydrochloride | 2021 |
AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar-Kyoto rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Deep Brain Stimulation; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Excitatory Amino Acid Agents; Hippocampus; Male; Optogenetics; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Receptors, AMPA; Stress, Psychological; Venlafaxine Hydrochloride | 2020 |
Venlafaxine and L-Thyroxine Treatment Combination: Impact on Metabolic and Synaptic Plasticity Changes in an Animal Model of Coexisting Depression and Hypothyroidism.
Topics: Animals; Depression; Disease Models, Animal; Drug Therapy, Combination; Frontal Lobe; Humans; Hypothyroidism; Male; Neuronal Plasticity; Rats; Rats, Inbred WKY; Thyroxine; Venlafaxine Hydrochloride | 2021 |
Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress.
Topics: Animals; Corpus Callosum; Cuprizone; Disease Models, Animal; Drug Evaluation, Preclinical; Febuxostat; Female; HEK293 Cells; Humans; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Neurotransmitter Agents; Risperidone; TRPA1 Cation Channel; Venlafaxine Hydrochloride | 2021 |
Effects of venlafaxine and chronic unpredictable stress on behavior and hippocampal neurogenesis of rat dams.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Doublecortin Protein; Female; Hippocampus; Immunohistochemistry; Maternal Behavior; Neurogenesis; Pregnancy; Rats; Rats, Wistar; Serotonin and Noradrenaline Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2017 |
Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress - A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies.
Topics: Animals; Antidepressive Agents; Clonidine; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Humans; Male; Mice; Molecular Docking Simulation; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Random Allocation; Serotonin Plasma Membrane Transport Proteins; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2017 |
Venlafaxine Attenuates the Development of Morphine Tolerance and Dependence: Role of L-Arginine/Nitric Oxide/cGMP Pathway.
Topics: Analgesics, Opioid; Animals; Arginine; Behavior, Animal; Brain; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Nitric Oxide; Nociceptive Pain; Signal Transduction; Time Factors; Venlafaxine Hydrochloride | 2018 |
The influence of aripiprazole and venlafaxine on the antidepressant-like effect observed in prenatally stressed rats (animal model of depression).
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Depression; Disease Models, Animal; Drug Therapy, Combination; Female; Locomotion; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2018 |
Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroinflammation and the l-arginine-nitric oxide pathway.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Brain; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione Peroxidase; Lipid Peroxidation; Male; Mice; Morphine; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitrites; Oxidative Stress; Pain Measurement; Signal Transduction; Venlafaxine Hydrochloride | 2018 |
Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Deep Brain Stimulation; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Male; Prefrontal Cortex; Rats; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2018 |
Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Ketamine; Male; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Disease Models, Animal; Freund's Adjuvant; Interleukin-17; Interleukin-6; Male; Matrix Metalloproteinase 3; Methotrexate; NF-kappa B; Oxidative Stress; RANK Ligand; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2019 |
The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.
Topics: Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Cell Death; Corticosterone; Cyclohexanols; Disease Models, Animal; Forkhead Box Protein O3; Forkhead Transcription Factors; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Venlafaxine Hydrochloride | 2013 |
Increased alcohol consumption in rats after subchronic antidepressant treatment.
Topics: Alcohol Drinking; Alcohols; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Addictive; Body Weight; Conditioning, Operant; Cyclohexanols; Disease Models, Animal; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Self Administration; Time Factors; Venlafaxine Hydrochloride | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Male; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Venlafaxine Hydrochloride | 2013 |
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
Topics: Administration, Intranasal; Alginates; Animals; Antidepressive Agents; Brain; Cyclohexanols; Depression; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Male; Motor Activity; Nanoparticles; Nasal Mucosa; Pharmacokinetics; Rats; Rats, Wistar; Swimming; Time Factors; Venlafaxine Hydrochloride | 2014 |
Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Doxepin; Hyperalgesia; Male; Morphine; Neuralgia; Pain Measurement; Pain Threshold; Rats; Sciatic Nerve; Venlafaxine Hydrochloride | 2014 |
Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Behavior, Animal; Citalopram; Disease Models, Animal; Hyperalgesia; Indans; Male; Methylamines; Mice; Mice, Inbred C57BL; Neuralgia; Neurotransmitter Uptake Inhibitors; Organoplatinum Compounds; Oxaliplatin; Venlafaxine Hydrochloride | 2015 |
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microscopy, Electron, Transmission; Neurons; Rats; Rats, Sprague-Dawley; Up-Regulation; Venlafaxine Hydrochloride | 2014 |
Assessment of in-utero venlafaxine induced, ROS-mediated, apoptotic neurodegeneration in fetal neocortex and neurobehavioral sequelae in rat offspring.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Apoptosis; bcl-2-Associated X Protein; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Exploratory Behavior; Female; Male; Microscopy, Electron; Neocortex; Nerve Degeneration; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Pyelectasis; Rats; Reactive Oxygen Species; Venlafaxine Hydrochloride | 2015 |
Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy.
Topics: Animals; Antidepressive Agents; Association Learning; Brain; Cannabinoid Receptor Antagonists; Carbolines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; GABA Antagonists; Ketamine; Male; Mood Disorders; Piperidines; Pyrazoles; Rats; Reaction Time; Reinforcement, Psychology; Rimonabant; Stress, Psychological; Venlafaxine Hydrochloride | 2015 |
LC-MS/MS based studies on the anti-depressant effect of hypericin in the chronic unpredictable mild stress rat model.
Topics: Amino Acids; Animals; Anthracenes; Antidepressive Agents; Behavior, Animal; Chromatography, Liquid; Corticosterone; Depression; Disease Models, Animal; Male; Neurotransmitter Agents; Perylene; Rats; Stress, Psychological; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2015 |
Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Corticotropin-Releasing Hormone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hypothalamus; Male; Mice; Olfactory Bulb; Receptors, Corticotropin-Releasing Hormone; Receptors, Vasopressin; Signal Transduction; Venlafaxine Hydrochloride | 2016 |
Allosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant Activity.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzazepines; Brain-Derived Neurotrophic Factor; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Neurons; Phenazocine; Receptors, sigma; Sigma-1 Receptor; Signal Transduction; Stress, Psychological; Swimming; Time Factors; Venlafaxine Hydrochloride | 2016 |
Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury.
Topics: Acetylcholinesterase; Animals; Arterial Pressure; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Hypertension, Renovascular; Male; Maze Learning; Nitrates; Nitrites; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Serotonin and Noradrenaline Reuptake Inhibitors; Superoxide Dismutase; Superoxides; Venlafaxine Hydrochloride | 2016 |
Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: Evidence of serotonergic and pro-inflammatory cytokine pathways.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Depressive Disorder; Disease Models, Animal; Dopamine; Folic Acid; Hindlimb Suspension; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Motor Activity; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Venlafaxine Hydrochloride | 2016 |
Coadministration of tramadol with aripiprazole and venlafaxine--The effect on spatial memory functions in male rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chronic Pain; Depression; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Spatial Memory; Tramadol; Venlafaxine Hydrochloride | 2016 |
Venlafaxine treatment after endothelin-1-induced cortical stroke modulates growth factor expression and reduces tissue damage in rats.
Topics: Animals; Antidepressive Agents; Astrocytes; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelin-1; Fibroblast Growth Factor 2; Gliosis; Male; Neuroprotective Agents; Random Allocation; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Stroke; Transforming Growth Factor beta1; Venlafaxine Hydrochloride | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
The antidepressant venlafaxine may act as a neurodevelopmental toxicant in cuttlefish (Sepia officinalis).
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Cell Proliferation; Decapodiformes; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Female; Monoamine Oxidase; Neurodevelopmental Disorders; Norepinephrine; Receptors, Glutamate; Serotonin; Statistics, Nonparametric; Venlafaxine Hydrochloride | 2016 |
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride | 2016 |
Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cerebral Cortex; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipramine; Ketamine; Male; Rats; Rats, Transgenic; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2017 |
Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Depression; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; Stress, Psychological; Venlafaxine Hydrochloride | 2016 |
Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
Topics: Animals; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Interleukin-1beta; Interleukin-6; Lipid Peroxidation; Male; Motor Activity; Neuroprotective Agents; Neurotransmitter Agents; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Rotarod Performance Test; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2017 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogens; Female; Fluoxetine; Injections, Subcutaneous; Motor Activity; Ovariectomy; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors; Swimming; Venlafaxine Hydrochloride | 2008 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous System Stimulants; Chronic Disease; Cyclohexanols; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Male; Methylene Blue; Mice; Mice, Inbred Strains; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Random Allocation; Swimming; Venlafaxine Hydrochloride | 2010 |
Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Therapy, Combination; Hyperalgesia; Male; Neuralgia; Pain Measurement; Rats; Rats, Wistar; Statistics as Topic; Tramadol; Venlafaxine Hydrochloride | 2009 |
Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA3 Region, Hippocampal; Cyclohexanols; Dentate Gyrus; Disease Models, Animal; Food Preferences; Hippocampus; Imipramine; In Situ Hybridization; Locomotion; Male; Maze Learning; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saccharin; Stress, Psychological; Sweetening Agents; Swimming; Time Factors; Venlafaxine Hydrochloride | 2010 |
Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Arginine; Brain; Catalase; Cyclic GMP; Cyclohexanols; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Enzyme Inhibitors; Glutathione; Ischemic Attack, Transient; Lipid Peroxidation; Mice; Models, Biological; Nitric Oxide; Signal Transduction; Trazodone; Venlafaxine Hydrochloride | 2010 |
The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nitric Oxide; Swimming; Venlafaxine Hydrochloride | 2011 |
Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Biogenic Amines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Hindlimb Suspension; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Motor Activity; Neurotransmitter Agents; Pentobarbital; Reserpine; Sleep; Swimming; Venlafaxine Hydrochloride | 2011 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Random Allocation; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Venlafaxine Hydrochloride | 2011 |
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Female; Hippocampus; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Imaging; Norepinephrine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Radioligand Assay; Serotonin; Venlafaxine Hydrochloride | 2012 |
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride | 2011 |
Venlafaxine facilitates between-session extinction and prevents reinstatement of auditory-cue conditioned fear.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Conditioning, Psychological; Cues; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Fear; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors; Venlafaxine Hydrochloride | 2012 |
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chemical Fractionation; Cyclohexanols; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ethanol; Hippocampus; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Motor Activity; Norepinephrine; Phytotherapy; Plants, Medicinal; Prefrontal Cortex; Serotonin; Solvents; Time Factors; Venlafaxine Hydrochloride | 2012 |
Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Motor Activity; Multivariate Analysis; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Venlafaxine Hydrochloride | 2012 |
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride | 2012 |
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1 | 2012 |
Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Topics: Animals; Antidepressive Agents, Second-Generation; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Disease Models, Animal; Immunosuppressive Agents; Male; Microinjections; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sucrose; Tacrolimus; TOR Serine-Threonine Kinases; Venlafaxine Hydrochloride | 2013 |
Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Aspartic Acid Endopeptidases; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cell Proliferation; Cognition Disorders; Cyclohexanols; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Gene Expression Regulation; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Male; Maternal Deprivation; Membrane Proteins; Mitogen-Activated Protein Kinase 8; Peptide Fragments; Pregnancy; Rats; Rats, Wistar; Recognition, Psychology; Synaptophysin; tau Proteins; Venlafaxine Hydrochloride | 2013 |
Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Male; Metabolomics; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2013 |
Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Cyclohexanols; Dialysis Solutions; Disease Models, Animal; Enzyme Inhibitors; Hepatic Encephalopathy; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2002 |
Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.
Topics: alpha-Methyltyrosine; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fenclonine; Male; Mononeuropathies; Motor Activity; Naloxone; Narcotic Antagonists; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain.
Topics: Analgesics; Animals; Cyclohexanols; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Male; Pain Threshold; Pressure; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Tramadol; Venlafaxine Hydrochloride | 2003 |
Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
Topics: Analgesics; Animals; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Disease Models, Animal; Hyperalgesia; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Vincristine | 2003 |
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.
Topics: Animals; Antiemetics; Crystallography, X-Ray; Cyclohexanols; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrets; Humans; In Vitro Techniques; Male; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT3 Receptor Antagonists; Stereoisomerism; Structure-Activity Relationship; Venlafaxine Hydrochloride; Vomiting | 2006 |
Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cyclohexanols; Disease Models, Animal; Edema; Female; Male; Mice; Mice, Inbred BALB C; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2005 |
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Proliferation; Chronic Disease; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hippocampus; Neuronal Plasticity; Neurons; Quetiapine Fumarate; Rats; Restraint, Physical; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Stem Cells; Stress, Psychological; Venlafaxine Hydrochloride | 2006 |
Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Brain; Cerebral Cortex; Cyclohexanols; Depression; Disease Models, Animal; Housing, Animal; Lipid Peroxidation; Male; Medulla Oblongata; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Water Deprivation | 2007 |
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Behavior, Animal; Cyclohexanols; Disease Models, Animal; Dopamine; Fatigue Syndrome, Chronic; Glutathione; Lipid Peroxidation; Male; Maze Learning; Memory; Mice; Motor Activity; Norepinephrine; Oxidative Stress; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2008 |
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Disease Models, Animal; Hepatic Encephalopathy; Humans; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Safety; Stereoisomerism; Venlafaxine Hydrochloride | 2002 |